As of the present time, specialized therapies aimed at mitochondrial targets have yet to receive approval for clinical use
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole
Experimental observations suggest FOXO4-DRI could be relevant for exploring how proteasomal function might be preserved in cardiac tissues, with implications for studying age-associated heart conditions
The GLOW 70mg vial contains BPC-157 10mg (pentadecapeptide GEPPPGKPADDAGLV, CHNO, 1419.53 g/mol, CAS 137525-51-0), TB-500 10mg (synthetic thymosin beta 4, 43 residues N-terminally acetylated, CHNOS, 4963.4 g/mol, CAS 77591-33-4) and GHK-Cu 50mg (glycyl-L-histidyl-L-lysine copper(II) complex, CHCuNO, 403.9 g/mol, CAS 89030-95-5), co-lyophilised in a single container